Completed
Daratumumab in STK11 Mutated NSCLC
NCT05807048
- Conditions
- Non-small Cell Lung Cancer With STK11/LKB1 Mutation
- Locations
-
- NYU Langone Health New York, United States
Clinical trial condition
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
Explore clinical trials studying Non-small Cell Lung Cancer With STK11/LKB1 Mutation. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies